Table of Contents
Understanding Health Insurance Coverage for Critical Conditions
Recent updates to health insurance regulations in Vietnam, specifically Circular 01/2025/TT-BYT, have clarified the extent of coverage for individuals diagnosed with rare diseases, serious illnesses, or conditions requiring surgery or advanced technology interventions. This circular, effective January 1, 2025, directly addresses point A, clause 4, article 22 of the health insurance law, ensuring that patients receive appropriate financial support for necessary medical services.
Immediate entitlement to Services Upon Diagnosis
According to Nguyen Thai Hoc, a leading expert from the university Hospital of Medicine and Pharmacy in Ho Chi minh City, patients are now entitled to health insurance benefits as soon as a definitive diagnosis is made for a condition listed in the circular. This immediate entitlement aims to reduce the financial burden on patients and their families during critical times. Though, it’s critically important to note that certain conditions may have specific requirements or status criteria that must be met to qualify for full coverage.
Scenario: Coverage for Additional Diseases Discovered During Examination
To illustrate how the circular works in practice, consider a hypothetical situation outlined in example 2 of article 5, circular 01/2025/TT-CYT. If a patient is diagnosed with one of the 62 serious illnesses listed in appendix 1 of the circular and seeks treatment at a specialized hospital, their health insurance coverage will be resolute based on the following scenarios:
Case Studies: Pancreatic Cancer Diagnosis
Let’s examine the case of a patient initially diagnosed with pancreatic cancer (C25 health code) at hospital A, who then seeks further examination and treatment at a specialized hospital B.
-
Scenario 1: Confirmed Diagnosis at Specialized Hospital B
If hospital B confirms the diagnosis of malignant pancreatic tumor (C25), the patient is entitled to full benefits for the examination and treatment of pancreatic cancer at hospital B. Furthermore,if any other diseases or co-morbidities are discovered during the treatment of pancreatic cancer,the costs associated with examining and treating these additional conditions will also be covered,according to the extent and level of benefits prescribed by health insurance law.
-
scenario 2: Diagnosis Not Confirmed at Specialized hospital B
If hospital B determines that the patient does not have pancreatic cancer (C25), the patient is still entitled to coverage for the examination and diagnostic services provided at hospital B.
-
Scenario 3: Patient Requests Examination for Other Diseases
If the patient requests examination and treatment for other diseases in addition to the malignant pancreatic tumor (C25) at hospital B, they will only receive health insurance benefits for the examination and treatment of the pancreatic tumor.Coverage will not extend to the other diseases examined or treated at hospital B.
in the event of serious illness, even after examining and diagnosing other pathologies, health insurance remains available for examinations and treatments carried out for other pathologies, following the appropriate procedures. If the patient asks to be examined for other pathologies,he will only be entitled to health insurance benefits for serious illnesses and not for other pathologies.
nguyen Thai Hoc, University Hospital of Medicine and Pharmacy
Implications for Patients and Healthcare providers
These regulations provide clarity and assurance for patients facing serious health challenges. By ensuring immediate access to health insurance benefits upon diagnosis, the circular aims to alleviate financial stress and promote timely access to necessary medical care. However, it is crucial for patients to understand the specific conditions and procedures for claiming benefits, especially when seeking treatment for multiple conditions simultaneously.
Healthcare providers also play a vital role in ensuring that patients receive the appropriate coverage. Accurate diagnosis, proper documentation, and adherence to the guidelines outlined in Circular 01/2025/TT-BYT are essential for facilitating seamless access to health insurance benefits for eligible patients.
